Term
hormonal elvelsi n emnstrual cycle |
|
Definition
follicles enalrge due to fsh stimualtion, they make estradiol, stimualting endometrium prolfieration.
E2 tirggers the prevoulatory surge of LHand FSH.
follciular rupture and ovualtin ooccurs, eleasing ovum.
ruptured follcie lbecomes corups luteum andp odrudces P and some E, P cuasing the endometrium to differneitate int o secreatoyr gnaldules. i nabsecne of pregnancy , corpus lutem ceasest o funciton, P and E leels drop and mensturation occurs |
|
|
Term
basis of oral contraceptives |
|
Definition
in pregnancay, post oulation progesteronand estrogen levels keep increasing, so there is no vovaultion. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
which pill has mroe stringetn on time requriements |
|
Definition
|
|
Term
adverse effecst of preoesterone pill |
|
Definition
commonly irregular menstrual bleeding. Sometimesi ncerases ecotpic pregnancy |
|
|
Term
|
Definition
when estrogen is contraindicated such as during breastfeeding where estrogen reduced breast milk |
|
|
Term
long term reversible contraception using progtesin |
|
Definition
implantation (etonogesterel)
Injection (medroxyproegsteron acetatte (mpa)). IU (levonogesterel) |
|
|
Term
|
Definition
hormonal conraception, preveniton of endometrial hyeprpleasia due to unospposed estrogen, secondary ammenorhea, endometriosis, ndometrial cancer, lutealsupporti nIF protocols, prevention of preterm birth. |
|
|
Term
|
Definition
low dose- ovulatory cessation incossitent, most of effects is cervicual muscoas thickening, reducing sperm viabiity and penetration
intermediate dose: soem follicular development, more consistiently inbhiting ovulation. same cervicual muc changes occur.
High dose, comepletley inhibits follciualr developmetn and ovualtion.
Endometrium- thin/atorphic interfeing with implanation of blastocyst |
|
|
Term
how does progesterone exert its effects |
|
Definition
e2 decreasesfamplitude of fsh anwd lh, but triggers surge ofLH mid cycle. P4 decrases frequency o GNrh, and thus frency of LH/FSH |
|
|
Term
progesteron receptors fucntioning |
|
Definition
both oded by hPR. pr-b contributs to prolfieration, Pr-A isoform is necessary to oppose estrogeni nduced prolfieraiton.
Estrogen is necessary to induce hpR epressioin in endometrium |
|
|
Term
|
Definition
focus mainly on estrogen , progesterone, and inhibotrs: antagonists,agonists, selective agoanists |
|
|
Term
|
Definition
the estrogen level remains constant while progesteron increases in monphasic biphasic triphasic etc. |
|
|
Term
|
Definition
ehtinyl estradiol or mestranol- mestranol is m etabolized to EE |
|
|
Term
|
Definition
irregular menstrua lbleeding ,ammenohrea, headaches, blaoting ,a nd fatigue |
|
|
Term
cotnious COC pill advantage |
|
Definition
cuts cycle to once every 3 months |
|
|
Term
natural huma nesdtrogen names |
|
Definition
e1 (estrone) , e2 (eastradiol), e3 - estriol |
|
|
Term
most potent human estrogen |
|
Definition
|
|
Term
least active human estrogen |
|
Definition
|
|
Term
|
Definition
Era: foudn in endometrium, breast cancer,ovarian celsl and hypothalamus
ErB: kidney, brain. the differnet estrogens differentiall yb ind to each receptor |
|
|
Term
ethinylestradiol metabolci features |
|
Definition
17a ethinyl group as wel las 3 m rethyl groups inhibit hydroxylation and sfulation respectively, > Decreased meatbolism leads to inccreased oral bioavialbiltily |
|
|
Term
estrogen med contradincations |
|
Definition
MI, stroke or v eous thromboemsbolism . caution with smokers adn obese. |
|
|
Term
estrogen site of metabolization |
|
Definition
|
|
Term
|
Definition
|
|
Term
combined oral concentrative |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
levonogesterol adverse effects |
|
Definition
nausea, abdominal pain,votmitting. DETERIOATION IN glucose tolerance, DIABETIC women need to be monitored |
|
|
Term
COMBINED ORAL CONCENTRATIVE adverse efects |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
anti progestin, disrupts follic ular maturaiton, mid cycle LH surge, and alter endometrium |
|
|
Term
ultipstail,mifepristone vs. levonogestrel/cocp timing of use |
|
Definition
uiltiprastal/m remai ne qulaly effective within time frframe, wheras levonogesterl are hte sooner hte more effective (because this one relies on inhibiting ovulation) |
|
|
Term
which emidcaiton also indictated for treating fibroid bleeding |
|
Definition
|
|
Term
side effects common to al lemergency contraceptives |
|
Definition
ectorpic pregnancy increase |
|
|
Term
contraception/abortion for emergency contraceptives |
|
Definition
levonorgestreal and COCp will not effect while pregnant, ulipristal and mifepristone mah ahve abortive effects. |
|
|
Term
|
Definition
|
|
Term
|
Definition
mifepristone- progestoerne recpeotr and glucoritocid recpetor antagonist, can be used through 9 weeks pregnancy (prostaglandine E1, as misprotol added later to induce uterine contraciton). |
|
|
Term
mifepristone abortive mechanism |
|
Definition
blocks uterine prostaglandin receptor causign decidual reakdown and deatchment ofblastocyst. this decreases hCG prodution and progesteron secretion from corpus luteum. hcg produciton down and progestone secrestion from corpus lutem down. this casuesf urhter decidual reakdown. you icnraese uterine prostaglandian and epxulsion of detached blastorcyst. |
|
|
Term
drug used tot reat heyeprglycemia |
|
Definition
mefipristone due to glucotiroicd receptor activity. |
|
|
Term
Diethylstilbesterol (DES) |
|
Definition
synthetic estrogen, origianlly used to prevent miscarragies, hwoever causes cancer andi nfertility. |
|
|
Term
|
Definition
causebreast cance in hromone replacement therapy.
caused repdocutive deformities and cacners in the children |
|
|
Term
|
Definition
be rest, avoid aspiorin/nsaids, also progesterone supplement.
unlike to do harm, hwoever no clear indication thati t works |
|
|
Term
predinosoloen nad misscarriage |
|
Definition
believe that tehere is aroel for uterine natural kilelr cells. prednisolone ay preent this |
|
|
Term
|
Definition
bascially abbort it via mifepristone or misporostl |
|
|
Term
|
Definition
hypertension- new onset, which causes peripehral edema, renal/hepatic dyfucntion and seizures. |
|
|
Term
|
Definition
DONT use RAAS antagonists. use a-adrenecic agonists. and hydralazine for severe cases. mGso4 to prevvent seizure and saefe to use. |
|
|
Term
labor repressants tocolytics |
|
Definition
work via relaxing smooth muscle.
B2 agonists, calcium channel blockers- nifedippine,
oxytocin antagonist.
Nsadis-
mgSo4 |
|
|
Term
|
Definition
oxytocin antagonist, used as labor repressant. |
|
|
Term
|
Definition
nsaid used for labor repression |
|
|
Term
mgso4 as labor reperssant |
|
Definition
calcium chanel blcoekr which inhibit myosin light chains |
|
|
Term
|
Definition
oxytocin,
misprostol
ergots- associated with severe side effects, but effect. |
|
|
Term
lactation natural process |
|
Definition
increases i estrogen produces prolactin, starting alctation process, oxytocin stimulates labor and stimualtes milk ejeciton during lactation. cobination contraceptives can be useful for this. |
|
|
Term
|
Definition
promotes lactatation, herbal galactagoggues,
pharmacolgoical: dompaine atnagonists |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
can sdimply nto stimautle the brest- medically- cabergoline- potent dopamine agonist |
|
|
Term
selective estergoen receptor modulator target organas |
|
Definition
beneficial efffect for bone and cv system however increased risk of breast and tuerine cancer |
|
|
Term
|
Definition
|
|
Term
tamoxsifen agonist and antoagnist effect |
|
Definition
antaognist on breast tisue parial agonist on uterine and bone tissues. |
|
|
Term
tamoxifen pharmacokinetics |
|
Definition
ac tive metaoblite 4 hydroyxtamoxifen. |
|
|
Term
|
Definition
derivative of tamoxifen with simliar profertes as tamoxifen |
|
|
Term
|
Definition
increased risk of endometrial carcinoma |
|
|
Term
raloxifene receptor selecitivty |
|
Definition
serm , nonsteroidral serm with estrogn actions on bone, and antiestrogenic aciotns on uterus and breast. |
|
|
Term
|
Definition
treamtent of osteoperisis and breast cancer |
|
|
Term
side effects of raloxifene-tamoxifene |
|
Definition
hot flashes leg gramps increased dvt and pulmoanr yembolism |
|
|
Term
|
Definition
pure estrogen antagonisdt |
|
|
Term
|
Definition
met breast cancer restant to tamoxifen |
|
|
Term
fulvestrant adva ntage to tamoxifen |
|
Definition
laso downregulats era receptor. |
|
|
Term
fulcvestrant adverse effects |
|
Definition
some of the same wones as tamoxifen also crosses the PLACENTA |
|
|
Term
|
Definition
tyep i irreversible steroids. similar to andoraestnedione. can bind to aromatase. - causign suicicdei nbhition. |
|
|
Term
|
Definition
dfor postmenopasual women with er positive earl ybreast cancer. more effective tha ntamox |
|
|
Term
|
Definition
operates simliar to exemstanebut no logne rused ue to poro oral bioavailbliyt. |
|
|
Term
|
Definition
type II reversible nonsteroid aromatasei nbhitor. |
|
|
Term
|
Definition
potmenopausal women with lcoalized er positive breast cancer, firstl ine treatmetn ofllowing tamox |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
aromatase inbhitiors only useful in postmenopausal woman |
|
Definition
useful sa an alaternative for to esterogen selectives, |
|
|
Term
|
Definition
weak androgen. inbhiitor of gonadal funciton i nthe treatemtn of endometriosis,
adverseefewfcts causel imited use. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
stimualte gnrh receptors, cause intial flare decreasing lh and fsh secretion supresisng steeroidigeness |
|
|
Term
|
Definition
advances prodstate cancer, endometriosis, and advanced bread cancer. |
|
|
Term
gnrh agonists adverse effects |
|
Definition
fetal harm, hypoestrogenism |
|
|
Term
|
Definition
do not transiently icnrese sex hormones, avoiding intial flare. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
inhibion of premature lh surges in women withovarianstimaultion can asl obe used for endometriosis |
|
|